Clinical trial
Resveratrol for the Prevention of Bone Loss in Postmenopausal Women
NCT06250283 is registered in ClinicalTrials.gov with University of Delaware as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Resveratrol for the Prevention of Bone Loss in Postmenopausal Women
- Lead sponsor
- University of Delaware
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 2, 2024
- Completion date
- January 30, 2026
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
low bone mass